Ray continued, “We’re also delighted to acknowledge Martin and Greg’s contributions to Synthekine with their new roles. Martin’s deep insights into cytokine biology and immunology were being instrumental to shaping the event of STK-012, our first-in-class alpha/beta biased IL-two. Its special mechanism expands the therapeutic index of IL-two, amongst The https://httpswwwzosanopharmacomte69146.digitollblog.com/36471460/https-www-zosanopharma-com-technology-an-overview